Last updated: April 10, 2025
Sponsor: Indiana University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism
Autism Spectrum Disorder (Asd)
Treatment
Eyelink Portable Duo
Clinical Study ID
NCT06703125
23171
1R01HD116441-01
Ages 24-72 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Children enrolled in the Tabiri study (R01HD104552)
CHEU or CHUU
Children ages 24-72 months
Caregivers of children must speak Kiswahili (local language) or English.
Exclusion
Exclusion Criteria:
- There will be no specific exclusion criteria. We anticipate that a small number ofCHEU and CHUU will develop HIV prior to enrollment in the current study; thesechildren will be included and will follow all general study procedures.
Study Design
Total Participants: 850
Treatment Group(s): 1
Primary Treatment: Eyelink Portable Duo
Phase:
Study Start date:
February 11, 2025
Estimated Completion Date:
February 28, 2029
Study Description
Connect with a study center
Moi Teaching and Referral Hospital
Eldoret,
KenyaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.